In addition, the lncRNA CDKN2B antisense RNA 1 gene can inhibit gemcitabine sensitivity via the induction of WNT signaling in bladder urothelial carcinoma [32]. The gene discussed is CDKN2B; the disease is bladder transitional cell carcinoma.